[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Various Diseases Clinical Trial Scenarios in H1 2016 Worldwide Reviewed in GlobalData Reports Available at MarketPublishers.com

24 Feb 2016 • by Natalie Aster

LONDON – TD The Market Publishers, Ltd. is excited to announce that GlobalData pipeline reviews of various diseases worldwide have been recently added to its catalogue.

These in-demand research publications provide high-level, unbiased data relating to the clinical trials on the various diseases. Each report includes a comprehensive overview of trial numbers and their average enrollment in top countries performed globally. In-depth coverage of the respective indication clinical trials is provided based on region, nation (G7 and E7), stage, trial status, status of end points, and by sponsor type. Each research report offers detailed information on distinguished drugs for ongoing trials by the number of trials currently in progress. Details about all the unaccomplished trials along with the reason for it are available. These reports contain deep reviews of the top firms involved, enlisting all trials (title of the trial, stage, and status) with respect to the company. The most current news for the last three months are also covered in each pipeline review.

World Clinical Trials Reviews are available for the following indications:

Reasons to Buy:

  • get help with the formulation of key business investment strategies;
  • discover important locations for performing clinical trials thus saving your time and cost;
  • identify key business opportunities by gaining understanding of the world clinical trials market;
  • get insights into clinical trials count and enrollment trends by country in the world therapeutics marketplace;
  • be able to easily perform clinical trial assessment of the pertinent indication on a global level, as well as region-and country-wise;
  • etc.

More studies by the publisher can be found at GlobalData page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 

Analytics & News

Weekly Digest